(Q44487857)

3 December 2017

title

Blockade of atrial angiotensin II type 1 receptors: a novel antiarrhythmic strategy to prevent atrial fibrillation? (English)

1 reference

3 December 2017

0 references

2

Andreas Goette

1 reference

3 December 2017

Helmut U Klein

1

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Journal of the American College of Cardiology

3 December 2017

published in

1 reference

3 December 2017

volume

41

1 reference

3 December 2017

issue

12

1 reference

3 December 2017

page(s)

2205-2206

1 reference

New ideas about atrial fibrillation 50 years on.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Pathology of atrial fibrillation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Signal transduction systems and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Activation Delay After Premature Stimulation in Chronically Diseased Human Myocardium Relates to the Architecture of Interstitial Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900469-8

7 January 2021

10.1016/S0735-1097(03)00469-8

Identifiers

DOI

1 reference

3 December 2017

1 reference